Socialguy, what I would like to know is what happened in the US...

Socialguy, what I would like to know is what happened in the US around 10.45 am yesterday?

Someone in the know over there I believe?

Novogen Limited (NVGN)

-NasdaqCM
2.79 0.25(9.84%) 06:00

Add to Portfolio

	Prev Close:	2.54
1	Open:	2.55
2	Bid:	2.82 x 100
3	Ask:	3.75 x 2000
4	1y Target Est:	3.51
5	Beta:	-1.0746
6	Next Earnings Date:	N/A

	Day's Range:	2.51 - 2.79
1	52wk Range:	1.51 - 9.50
2	Volume:	127,259
3	Avg Vol (3m):	179,006
4	Market Cap:	47.22M
5	P/E (ttm):	N/A
6	EPS (ttm):	-0.53
7	Div & Yield:	N/A (N/A)

Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines

• Novogen (NVGN) Conducts Scientific Review of R&D ProgramZacks(Tue 1 Sep)
• Novogen Announces The Outcome Of A Comprehensive Science ReviewPR Newswire(Mon 31 Aug)
• Newly Appointed Acting CEO Outlines Immediate Plans for NovogenPR Newswire(Thu 30 Jul)
• Novogen Appoints Iain Ross as Acting CEO and Re-appoints Him to the BoardPR Newswire(Wed 22 Jul)
• Anisina Receives Orphan Drug Designation from FDA for NeuroblastomaPR Newswire(Thu 16 Jul)
• Pre-clinical Studies Suggest Anisina May Improve Chemotherapy Effectiveness in Childhood CancerPR Newswire(Tue 14 Jul)
• H.C. Wainwright: Time To Buy NovogenBenzinga(Wed 1 Jul)
• Coverage initiated on Novogen by H.C. WainwrightBriefing.com(Wed 1 Jul)
• Novogen Announces the Chairman's Address at the Company's General MeetingPR Newswire(Wed 24 Jun)
• Anisina on Track to Enter Clinic in 2016PR Newswire(Wed 24 Jun)

» More Headlines for NVGN
Press Releases

• Novogen Announces The Outcome Of A Comprehensive Science ReviewPR Newswire(Mon 31 Aug)
• Newly Appointed Acting CEO Outlines Immediate Plans for NovogenPR Newswire(Thu 30 Jul)
• Novogen Appoints Iain Ross as Acting CEO and Re-appoints Him to the BoardPR Newswire(Wed 22 Jul)

» More Press Releases for NVGN

Novogen Limited (NVGN)

-NasdaqCM
2.79 0.25(9.84%) 06:00

Add to Portfolio​

	Prev Close:	2.54
1	Open:	2.55
2	Bid:	2.82 x 100
3	Ask:	3.75 x 2000
4	1y Target Est:	3.51
5	Beta:	-1.0746
6	Next Earnings Date:	N/A

	Day's Range:	2.51 - 2.79
1	52wk Range:	1.51 - 9.50
2	Volume:	127,259
3	Avg Vol (3m):	179,006
4	Market Cap:	47.22M
5	P/E (ttm):	N/A
6	EPS (ttm):	-0.53
7	Div & Yield:	N/A (N/A)

Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines​

• Novogen (NVGN) Conducts Scientific Review of R&D ProgramZacks(Tue 1 Sep)
• Novogen Announces The Outcome Of A Comprehensive Science ReviewPR Newswire(Mon 31 Aug)
• Newly Appointed Acting CEO Outlines Immediate Plans for NovogenPR Newswire(Thu 30 Jul)
• Novogen Appoints Iain Ross as Acting CEO and Re-appoints Him to the BoardPR Newswire(Wed 22 Jul)
• Anisina Receives Orphan Drug Designation from FDA for NeuroblastomaPR Newswire(Thu 16 Jul)
• Pre-clinical Studies Suggest Anisina May Improve Chemotherapy Effectiveness in Childhood CancerPR Newswire(Tue 14 Jul)
• H.C. Wainwright: Time To Buy NovogenBenzinga(Wed 1 Jul)
• Coverage initiated on Novogen by H.C. WainwrightBriefing.com(Wed 1 Jul)
• Novogen Announces the Chairman's Address at the Company's General MeetingPR Newswire(Wed 24 Jun)
• Anisina on Track to Enter Clinic in 2016PR Newswire(Wed 24 Jun)

» More Headlines for NVGN
Press Releases​

• Novogen Announces The Outcome Of A Comprehensive Science ReviewPR Newswire(Mon 31 Aug)
• Newly Appointed Acting CEO Outlines Immediate Plans for NovogenPR Newswire(Thu 30 Jul)
• Novogen Appoints Iain Ross as Acting CEO and Re-appoints Him to the BoardPR Newswire(Wed 22 Jul)

» More Press Releases for NVGN

Check out the large Spike in Volume around 10.45AM in the US Yesterday.​

	Column 1
1

There has to be some news coming IMHO>